GRK2 and Graves disease: It has been demonstrated that c-TSHR autoantibodies (c-TSHR-Abs), while not activating G protein-dependent signaling, can activate GRK2 and downstream signaling pathways, resulting in the accumulation of intracellular inclusion bodies, ROS production, and cell death, which exacerbates the severity of Graves' disease [92].